David Slinkman - May 15, 2023 Form 4 Insider Report for QUAKER CHEMICAL CORP (KWR)

Role
SVP - Chief Technology Officer
Signature
Victoria K. Gehris, Attorney-in-Fact for David Slinkman
Stock symbol
KWR
Transactions as of
May 15, 2023
Transactions value $
-$210,142
Form type
4
Date filed
5/16/2023, 04:30 PM
Previous filing
Apr 3, 2023
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KWR Common Stock Options Exercise $114K +736 +15.72% $154.92 5.42K May 15, 2023 Direct
transaction KWR Common Stock Sale -$150K -736 -13.58% $204.20 4.68K May 15, 2023 Direct
transaction KWR Common Stock Options Exercise $320K +2.34K +50% $136.64 7.02K May 15, 2023 Direct
transaction KWR Common Stock Sale -$478K -2.34K -33.33% $204.20 4.68K May 15, 2023 Direct
transaction KWR Common Stock Options Exercise $108K +606 +12.94% $178.29 5.29K May 15, 2023 Direct
transaction KWR Common Stock Sale -$124K -606 -11.46% $204.20 4.68K May 15, 2023 Direct
holding KWR Common Stock 62 May 15, 2023 By 401(k) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -736 -100% $0.00* 0 May 15, 2023 Common Stock 736 $154.92 Direct F2
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -2.34K -100% $0.00* 0 May 15, 2023 Common Stock 2.34K $136.64 Direct F3
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -606 -33.32% $0.00 1.21K May 15, 2023 Common Stock 606 $178.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Information based on reporting person's Plan Statement as of March 31, 2023.
F2 The options for this grant vested in three annual installments: 737 shares on February 25, 2020; 737 shares on February 25, 2021; and 736 shares on February 25, 2022.
F3 The options for this grant vested in three annual installments: 781 shares on March 30, 2021; 780 shares on March 30, 2022; and 780 shares on March 30, 2023.
F4 The options for this grant vest in three annual installments: 606 shares on March 16, 2023; 606 shares on March 16, 2024; and 607 shares on March 16, 2025.